Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Nuclear Medicine Market From 2025 To 2034?
The nuclear medicine market size has shown rapid expansion in recent years. Projections indicate it will increase from $8.93 billion in 2024 to $10.18 billion in 2025, achieving a compound annual growth rate (CAGR) of 14.0%. The market’s growth in previous periods can be linked to factors such as an aging population, advancements in cancer diagnosis and staging, various cardiology applications, the impact of neurological disorders, and favorable regulatory approvals.
The nuclear medicine market is anticipated to experience significant expansion over the coming years. Its valuation is projected to reach $15.64 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.3%. Factors driving this growth during the forecast period include advancements in personalized medicine, intensive research in oncology and neurology, the adoption of sustainable practices, continued research and development efforts, and the expansion of telemedicine services. Key trends anticipated for this period encompass radioimmunotherapy, the integration of hybrid imaging techniques, the application of artificial intelligence (AI), the development of emerging radiopharmaceuticals, and continuous improvements in diagnostic imaging.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp
Which Factors And Drivers Are Influencing The Nuclear Medicine Market In 2025?
The rising consistency and occurrence of cardiovascular disease (CVD) and cancer are anticipated to drive the expansion of the nuclear medicine market in the future. Cardiovascular diseases (CVDs) encompass various conditions affecting the heart and blood vessels, while cancer is characterized by uncontrolled cell growth that can disseminate throughout the body. Nuclear cardiac imaging offers a faster diagnostic tool for heart-related illnesses. Furthermore, nuclear medicine therapy provides a cancer treatment approach, which can be employed alongside or following other interventions like surgery and chemotherapy. Consequently, the increasing consistency and incidence of cardiovascular disease and cancer are fueling the demand within the nuclear medicine market. An example of this trend is observed in January 2023, when the American Cancer Society Inc., a US-based non-profit health organization, projected 1,958,310 new cancer diagnoses in the US for 2023. This represents an uptick from over 1,918,030 new cancer cases recorded in 2022. Hence, the expanding consistency and prevalence of cardiovascular diseases and cancer are acting as key drivers for the nuclear medicine market.
What Are The Primary Types Of Segments Analyzed In The Nuclear Medicine Market?
The nuclear medicinemarket covered in this report is segmented –
1) By Type: Diagnostic; Therapeutic
2) By Application: Cardiology; Lymphoma; Thyroid; Neurology; Oncology; Other Application
3) By End-User: Hospitals and Clinics; Diagnostic Centers; Other End Users
Subsegments:
1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT); Positron Emission Tomography (PET); Gamma Cameras; Radiopharmaceuticals for Imaging; Other Diagnostic Imaging Techniques
2) By Therapeutic: Radiopharmaceuticals for Targeted Therapy; Beta Emitters; Alpha Emitters; Radiosynovectomy Agents; Other Therapeutic Applications
What Are The Latest Industry Trends Transforming The Nuclear Medicine Market?
Leading companies in the nuclear medicine market are concentrating on developing innovative solutions, such as nuclear medicine cyclotrons, to improve radiopharmaceutical production and enhance diagnostic imaging capabilities. Nuclear medicine cyclotrons are specialized particle accelerators that generate radioactive isotopes for medical imaging and therapy by directing high-energy particles at target materials, enabling the synthesis of radiopharmaceuticals used in procedures like positron emission tomography (PET). For instance, in January 2024, GE Healthcare China, a US-based medical technology company, launched its first batch of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These advanced particle accelerators are critical for nuclear medicine, facilitating the production of medical isotopes employed in molecular imaging and therapeutic applications. This initiative aims to establish a comprehensive ecosystem for nuclear medicine, boosting capabilities in early disease detection and personalized treatment.
Who Are The Major Companies Operating In The Nuclear Medicine Market?
Major companies operating in the nuclear medicine market include Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Medtronic plc, Triad Isotopes Inc., FUJIFILM Holdings Corporation, Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., Global Medical Solutions LLC, Charles River Analytics Inc., Touchlight Genetics Ltd., Numares B.V., Tech-X Corporation, Karyopharm Therapeutics Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report
Which Region Currently Holds The Largest Share Of The Nuclear Medicine Market?
North America was the largest region in the nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Nuclear Medicine Market Report:
https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp
Browse Through More Reports Similar to the Global Nuclear Medicine Market 2025, By The Business Research Company
Electronic And Precision Equipment Repair And Maintenance Global Market Report 2025
Research Antibodie And Reagent Global Market Report 2025
Catalyst Fertilizer Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/catalyst-fertilizer-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model